Hydreight Technologies Inc. (TSXV:NURS)
Canada · Delayed Price · Currency is CAD 3.970
-0.020 (-0.50%)
At close: Aug 28, 2026
Hydreight Technologies Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 24.21 | 15.65 | 1.19 | 1.78 | 2.43 | 0.01 |
Cash & Short-Term Investments | 24.21 | 15.65 | 1.19 | 1.78 | 2.43 | 0.01 |
Cash Growth | 300.62% | 1218.45% | -33.46% | -26.67% | 38019.75% | -80.53% |
Accounts Receivable | 10.56 | 1.63 | -0 | 0.02 | 0.01 | - |
Other Receivables | 0.13 | 0.1 | 0.08 | - | 0.01 | 0.01 |
Receivables | 10.68 | 1.72 | 0.08 | 0.02 | 0.02 | 0.01 |
Inventory | - | - | - | 0.1 | 0.1 | - |
Prepaid Expenses | 3.79 | 3.38 | 0.09 | 0.12 | 0.06 | 0.03 |
Other Current Assets | 0.25 | 0.19 | 0.23 | 0.03 | - | - |
Total Current Assets | 38.94 | 20.95 | 1.58 | 2.06 | 2.62 | 0.05 |
Property, Plant & Equipment | 0.01 | 0 | 0 | 0 | 0.02 | - |
Long-Term Investments | 10.54 | 10.27 | - | - | - | - |
Other Intangible Assets | 2.81 | 2.54 | 1.53 | 0.39 | 0.26 | 0.38 |
Other Long-Term Assets | - | - | - | 0.14 | - | - |
Total Assets | 52.3 | 33.75 | 3.11 | 2.6 | 2.89 | 0.43 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.29 | 1.3 | 1.01 | 0.83 | 0.6 | 0.35 |
Accrued Expenses | 1.36 | 0.92 | 0.67 | 0.7 | 0.04 | 0.51 |
Short-Term Debt | - | - | - | 0.81 | 0.76 | - |
Current Portion of Leases | - | - | - | - | 0.02 | - |
Current Income Taxes Payable | 0.12 | 0.12 | - | - | - | - |
Current Unearned Revenue | 3 | 2.15 | 1.73 | 1.69 | 1.7 | 0.29 |
Other Current Liabilities | 1.15 | 0.78 | 0.63 | 0.37 | 0.1 | 0.06 |
Total Current Liabilities | 6.92 | 5.26 | 4.04 | 4.41 | 3.23 | 1.2 |
Long-Term Debt | 8.96 | 8.77 | 0.83 | - | - | - |
Long-Term Unearned Revenue | 0.01 | 0.02 | 0 | 0.03 | 0.02 | 0.01 |
Total Liabilities | 15.89 | 14.05 | 4.88 | 4.43 | 3.25 | 1.21 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 35.31 | 25.09 | 7.1 | 6.53 | 6.23 | 0 |
Retained Earnings | -4.85 | -7.44 | -9.13 | -8.73 | -6.79 | -0.79 |
Comprehensive Income & Other | 5.94 | 2.04 | 0.27 | 0.36 | 0.2 | 0.01 |
Shareholders' Equity | 36.41 | 19.7 | -1.77 | -1.83 | -0.36 | -0.78 |
Total Liabilities & Equity | 52.3 | 33.75 | 3.11 | 2.6 | 2.89 | 0.43 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8.96 | 8.77 | 0.83 | 0.81 | 0.78 | - |
Net Cash (Debt) | 15.25 | 6.88 | 0.35 | 0.97 | 1.65 | 0.01 |
Net Cash Growth | 191.54% | 1849.10% | -63.69% | -41.17% | 25797.27% | -80.53% |
Net Cash Per Share | 0.31 | 0.15 | 0.01 | 0.03 | 0.47 | - |
Filing Date Shares Outstanding | 53.67 | 53.39 | 44.86 | 38.32 | 37.84 | - |
Total Common Shares Outstanding | 53.42 | 49.63 | 40.32 | 38.32 | 37.84 | - |
Working Capital | 32.02 | 15.69 | -2.46 | -2.34 | -0.61 | -1.15 |
Book Value Per Share | 0.68 | 0.40 | -0.04 | -0.05 | -0.01 | - |
Tangible Book Value | 33.6 | 17.16 | -3.3 | -2.22 | -0.61 | -1.17 |
Tangible Book Value Per Share | 0.63 | 0.35 | -0.08 | -0.06 | -0.02 | - |